Literature DB >> 33860174

Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Calvin Ly1, Alexandra C Greb1, Maxemiliano V Vargas2, Whitney C Duim1, Ana Cristina G Grodzki3, Pamela J Lein3, David E Olson1,4,5.   

Abstract

Cortical neuron atrophy is a hallmark of depression and includes neurite retraction, dendritic spine loss, and decreased synaptic density. Psychoplastogens, small molecules capable of rapidly promoting cortical neuron growth, have been hypothesized to produce long-lasting positive effects on behavior by rectifying these deleterious structural and functional changes. Here we demonstrate that ketamine and LSD, psychoplastogens from two structurally distinct chemical classes, promote sustained growth of cortical neurons after only short periods of stimulation. Furthermore, we show that psychoplastogen-induced cortical neuron growth can be divided into two distinct epochs: an initial stimulation phase requiring TrkB activation and a growth period involving sustained mTOR and AMPA receptor activation. Our results provide important temporal details concerning the molecular mechanisms by which next-generation antidepressants produce persistent changes in cortical neuron structure, and they suggest that rapidly excreted psychoplastogens might still be effective neurotherapeutics with unique advantages over compounds like ketamine and LSD.

Entities:  

Year:  2020        PMID: 33860174      PMCID: PMC8033616          DOI: 10.1021/acsptsci.0c00065

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  76 in total

1.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

2.  Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.

Authors:  Sriparna Ghosal; Eunyoung Bang; Wenzhu Yue; Brendan D Hare; Ashley E Lepack; Matthew J Girgenti; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2017-06-23       Impact factor: 13.382

3.  Psychedelic Psychiatry's Brave New World.

Authors:  David Nutt; David Erritzoe; Robin Carhart-Harris
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

4.  Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.

Authors:  Hiroyuki Koike; Shigeyuki Chaki
Journal:  Behav Brain Res       Date:  2014-06-05       Impact factor: 3.332

5.  In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.

Authors:  B R Sitaram; L Lockett; R Talomsin; G L Blackman; W R McLeod
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

6.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

7.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

8.  Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.

Authors:  Patrick C Dolder; Yasmin Schmid; Manuel Haschke; Katharina M Rentsch; Matthias E Liechti
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-24       Impact factor: 5.176

9.  Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics.

Authors:  David E Olson
Journal:  J Exp Neurosci       Date:  2018-09-19

10.  Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex.

Authors:  Victoria Phoumthipphavong; Florent Barthas; Samantha Hassett; Alex C Kwan
Journal:  eNeuro       Date:  2016-04-04
View more
  12 in total

Review 1.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

Review 2.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162

Review 3.  The role of serotonin neurotransmission in rapid antidepressant actions.

Authors:  A L Pehrson; D Roberts; A Khawaja; R McNair
Journal:  Psychopharmacology (Berl)       Date:  2022-03-25       Impact factor: 4.530

4.  Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.

Authors:  Ling-Xiao Shao; Clara Liao; Ian Gregg; Pasha A Davoudian; Neil K Savalia; Kristina Delagarza; Alex C Kwan
Journal:  Neuron       Date:  2021-07-05       Impact factor: 18.688

Review 5.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

6.  The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex.

Authors:  Lynette A Desouza; Madhurima Benekareddy; Sashaina E Fanibunda; Farhan Mohammad; Balaganesh Janakiraman; Utkarsha Ghai; Tamar Gur; Julie A Blendy; Vidita A Vaidya
Journal:  Front Mol Neurosci       Date:  2021-12-24       Impact factor: 5.639

Review 7.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

Review 8.  Serotonergic Psychedelics in Neural Plasticity.

Authors:  Kacper Lukasiewicz; Jacob J Baker; Yi Zuo; Ju Lu
Journal:  Front Mol Neurosci       Date:  2021-10-12       Impact factor: 6.261

9.  How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

Authors:  Manon van den Berg; Igor Magaraggia; Rudy Schreiber; Todd M Hillhouse; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2022-03-29       Impact factor: 4.415

10.  Engineering Safer Psychedelics for Treating Addiction.

Authors:  Jamie Peters; David E Olson
Journal:  Neurosci Insights       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.